Kinarus Therapeutics vs Molecure
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases
5 employees · est. 2017 · Basel, Switzerland
Molecure is the older company (2017 vs 2012); Molecure is the larger of the two.
Side-by-Side Comparison
| Metric | Kinarus Therapeutics | Molecure |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2012 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Warsaw, Poland |
| Employees | ||
| Employees | 5 | 85 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Secondary |
| Total Funding | ||
| Total Funding | $36.55M | $50.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 1 |
| Taxonomy | ||
| Taxonomy | Clinical-stage Pharmaceutical CompanyDrug DevelopmentViral DiseasesRespiratory DiseasesOphthalmic DiseasesP38 MAPK Inhibitor +9 | BiopharmaceuticalClinical StageSmall Molecule Drug DiscoveryImmunotherapyMedicinal ChemistryRespiratory Diseases +9 |
| Website | ||
| Website | kinarus.com | molecure.com |
About Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage pharmaceutical company based in Switzerland. Established in 2017, the company is dedicated to developing innovative treatments for viral, respiratory, and ophthalmic diseases. Their flagship drug candidate is an oral combination of a P38 mitogen-activated pro...
About Molecure
Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-cla...
Also comparing in this category
Comparing more than these two?
Get Kinarus Therapeutics, Molecure and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Kinarus Therapeutics compare?
A PDF of Kinarus Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Kinarus Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kinarus Therapeutics on 12 Sep 2024, and Molecure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
